These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36476560)
21. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes. Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240 [TBL] [Abstract][Full Text] [Related]
22. [Co-administration of intranasally delivered insulin and proinsulin C-peptide to rats with the types 1 and 2 diabetes mellitus restores their metabolic parameters.]. Derkach KV; Bondareva VM; Shpakov AO Adv Gerontol; 2017; 30(6):851-858. PubMed ID: 29608829 [TBL] [Abstract][Full Text] [Related]
23. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells. Murakami T; Inagaki N; Kondoh H Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205 [TBL] [Abstract][Full Text] [Related]
24. Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. Agostino NM; Chinchilli VM; Lynch CJ; Koszyk-Szewczyk A; Gingrich R; Sivik J; Drabick JJ J Oncol Pharm Pract; 2011 Sep; 17(3):197-202. PubMed ID: 20685771 [TBL] [Abstract][Full Text] [Related]
25. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538 [TBL] [Abstract][Full Text] [Related]
26. Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes (T2D) and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose. Dihingia A; Ozah D; Ghosh S; Sarkar A; Baruah PK; Kalita J; Sil PC; Manna P J Nutr Biochem; 2018 Feb; 52():103-114. PubMed ID: 29175667 [TBL] [Abstract][Full Text] [Related]
27. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. Goldfine AB; Simonson DC; Folli F; Patti ME; Kahn CR J Clin Endocrinol Metab; 1995 Nov; 80(11):3311-20. PubMed ID: 7593444 [TBL] [Abstract][Full Text] [Related]
28. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. Babu PV; Liu D; Gilbert ER J Nutr Biochem; 2013 Nov; 24(11):1777-89. PubMed ID: 24029069 [TBL] [Abstract][Full Text] [Related]
29. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Zaccardi F; Webb DR; Yates T; Davies MJ Postgrad Med J; 2016 Feb; 92(1084):63-9. PubMed ID: 26621825 [TBL] [Abstract][Full Text] [Related]
30. Physiological mechanisms of action of incretin and insulin in regulating skeletal muscle metabolism. Abdulla H; Phillips B; Smith K; Wilkinson D; Atherton PJ; Idris I Curr Diabetes Rev; 2014; 10(5):327-35. PubMed ID: 25323297 [TBL] [Abstract][Full Text] [Related]
31. Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes. Reifsnyder PC; Flurkey K; Te A; Harrison DE Aging (Albany NY); 2016 Nov; 8(11):3120-3130. PubMed ID: 27922820 [TBL] [Abstract][Full Text] [Related]
32. A Human Randomized Controlled Trial Comparing Metabolic Responses to Single and Repeated Hypoglycemia in Type 1 Diabetes. Bengtsen MB; Støy J; Rittig NF; Voss TS; Magnusson NE; Svart MV; Jessen N; Møller N J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32927476 [TBL] [Abstract][Full Text] [Related]
33. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission. Gosmanov AR; Smiley D; Robalino G; Siqueira JM; Peng L; Kitabchi AE; Umpierrez GE Diabetes Care; 2010 Apr; 33(4):854-60. PubMed ID: 20067967 [TBL] [Abstract][Full Text] [Related]
34. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes. Chan CL; Pyle L; Morehead R; Baumgartner A; Cree-Green M; Nadeau KJ Pediatr Diabetes; 2017 Sep; 18(6):470-477. PubMed ID: 27503277 [TBL] [Abstract][Full Text] [Related]
35. Amylase-Dependent Regulation of Glucose Metabolism and Insulin/Glucagon Secretion in the Streptozotocin-Induced Diabetic Pig Model and in a Rat Pancreatic Beta-Cell Line, BRIN-BD11. Pierzynowska K; Oredsson S; Pierzynowski S J Diabetes Res; 2020; 2020():2148740. PubMed ID: 33294459 [TBL] [Abstract][Full Text] [Related]
36. Application of microRNAs in diabetes mellitus. Chen H; Lan HY; Roukos DH; Cho WC J Endocrinol; 2014 Jul; 222(1):R1-R10. PubMed ID: 24781254 [TBL] [Abstract][Full Text] [Related]
37. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Louvet C; Szot GL; Lang J; Lee MR; Martinier N; Bollag G; Zhu S; Weiss A; Bluestone JA Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18895-900. PubMed ID: 19015530 [TBL] [Abstract][Full Text] [Related]
38. Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes. Cusi K; Sanyal AJ; Zhang S; Hoogwerf BJ; Chang AM; Jacober SJ; Bue-Valleskey JM; Higdon AN; Bastyr EJ; Haupt A; Hartman ML Diabetes Obes Metab; 2016 Oct; 18 Suppl 2():50-58. PubMed ID: 27723227 [TBL] [Abstract][Full Text] [Related]
39. A novel combination of sitagliptin and melatonin ameliorates T2D manifestations: studies on experimental diabetic models. Patel R; Parmar N; Palit SP; Rathwa N; Begum R J Endocrinol Invest; 2023 Aug; 46(8):1597-1612. PubMed ID: 36692817 [TBL] [Abstract][Full Text] [Related]